Lisa Peraza - 13 Jan 2024 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
VP, Chief Accounting Officer
Signature
/s/ Lisa Peraza
Issuer symbol
HRTX
Transactions as of
13 Jan 2024
Net transactions value
-$1,625
Form type
4
Filing time
16 Jan 2024, 17:19:23 UTC
Previous filing
17 Oct 2023
Next filing
19 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HRTX Common Stock Options Exercise +552 +1% 55,374 13 Jan 2024 Direct F1
transaction HRTX Common Stock Options Exercise +1,289 +2.3% 56,663 13 Jan 2024 Direct F1
transaction HRTX Common Stock Tax liability $1,625 -756 -1.3% $2.15 55,907 13 Jan 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRTX Restricted Stock Units Options Exercise $0 -552 -25% $0.000000 1,656 13 Jan 2024 Common Stock 552 Direct F1, F3
transaction HRTX Restricted Stock Units Options Exercise $0 -1,289 -16% $0.000000 6,675 13 Jan 2024 Common Stock 1,289 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions.
F3 The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).
F4 The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021).